Lb Pharmaceuticals (LBRX) Other Working Capital Changes (2024 - 2026)
Lb Pharmaceuticals (LBRX) posted quarterly Other Working Capital Changes of -$99000.0 for Q1 2026, down 5050.0% year-over-year from $2000.0 in Q1 2025, and down 1.02% quarter-over-quarter from -$98000.0 in Q4 2025.
Powered by 
Analysis
Lb Pharmaceuticals (LBRX) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$99000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 5050.0% year-over-year to -$99000.0; the TTM figure through Mar 2026 stood at -$194000.0 (changed N/A YoY), while the FY2025 annual figure was -$134000.0, down 123.33% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$99000.0, down from -$98000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $11.3 million in Q4 2025, with the low at -$83000.0 in Q1 2025.
- The 3-year median for Other Working Capital Changes is $5.1 million (2024), against an average of $5.4 million.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes plunged 9900.0% in 2025, then slumped 5050.0% in 2026.
- Lb Pharmaceuticals' Other Working Capital Changes stood at $1000.0 in 2024, then slumped by 9900.0% to -$98000.0 in 2025, then dropped by 1.02% to -$99000.0 in 2026.
- Business Quant data shows LBRX's Other Working Capital Changes at -$99000.0 in Q1 2026, -$98000.0 in Q4 2025, and $2000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Lb Pharmaceuticals | 1.49 Bn | 1.49 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.07 Mn |
| Jun 30, 2026 | 4.07 Mn |
| Mar 31, 2026 | 10.22 Mn |
| Mar 31, 2026 | 10.22 Mn |
| Dec 31, 2025 | 11.30 Mn |
| Dec 31, 2025 | 11.30 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | -241,000.00 |
| Jun 30, 2025 | -241,000.00 |
| Mar 31, 2025 | -83,000.00 |
| Mar 31, 2025 | -83,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Dec 31, 2024 | -10,000.00 |